Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: Coupling to nitric oxide release

被引:90
作者
Fimiani, C
Mattocks, D
Cavani, F
Salzet, M
Deutsch, DG
Pryor, S
Bilfinger, TV
Stefano, GB [1 ]
机构
[1] SUNY Coll Old Westbury, Neurosci Res Inst, Multidisciplinary Ctr Study Aging, Old Westbury, NY 11568 USA
[2] Univ Sci & Tech Lille Flandres Artois, Ctr Biol Cellulaire, Lab Phylogenie Mol Annelides EA DRED 1027, Grp Neuroendocrinol Hirudinees, Villeneuve Dascq, France
[3] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA
[4] SUNY Stony Brook, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA
[5] SUNY Stony Brook, Dept Surg, Cardiac Res Program, Stony Brook, NY 11794 USA
关键词
endothelia; morphine; anadamide; calcium transients; nitric oxide; mu(3) receptor;
D O I
10.1016/S0898-6568(98)00060-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Both morphine and anandamide significantly stimulated cultured endothelial intracellular calcium level increases in a concentration-dependent manner in cells pre-loaded with fura 2/AM. Morphine is more potent than anandamide (approximately 275 us. 135 nM [Ca](i)), and the [Ca](i) for both ligands was blocked by prior exposure of the cells to their respective receptor antagonist, i.e., naloxone and SR 171416A. Various opioid peptides did not exhibit this ability, indicating a morphine-mu(3)-mediated process. In comparing the sequence of events concerning morphine's and anandamide's action in stimulating both [Ca](i) and nitric oxide production in endothelial cells, we found that the first event precedes the second by 40 +/- 8 sec. The opiate and cannabinoid stimulation of [Ca](i) was attenuated in cells leeched of calcium, strongly suggesting that intracellular calcium levels regulate cNOS activity. CELL SIGNAL 11;3:189-193, 1999. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:189 / 193
页数:5
相关论文
共 31 条
  • [1] GROWTH ARREST OF A MURINE MESANGIAL CELL-LINE BY TRANSFORMING GROWTH-FACTOR-BETA-1 IS ASSOCIATED WITH INHIBITION OF MITOGEN-INDUCED CA2+ MOBILIZATION
    BAFFY, G
    SHARMA, K
    SHI, WY
    ZIYADEH, FN
    WILLIAMSON, JR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (02) : 378 - 383
  • [2] Determinants of the G protein-dependent opioid modulation of neuronal calcium channels
    Bourinet, E
    Soong, TW
    Stea, A
    Snutch, TP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1486 - 1491
  • [3] OPIOID AND CANNABINOID RECEPTOR INHIBITION OF ADENYLYL CYCLASE IN BRAIN
    CHILDERS, SR
    FLEMING, L
    KONKOY, C
    MARCKEL, D
    PACHECO, M
    SEXTON, T
    WARD, S
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 654 : 33 - 51
  • [4] Production and physiological actions of anandamide in the vasculature of the rat kidney
    Deutsch, DG
    Goligorsky, MS
    Schmid, PC
    Krebsbach, RJ
    Schmid, HHO
    Das, SK
    Dey, SK
    Arreaza, G
    Thorup, C
    Stefano, G
    Moore, LC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) : 1538 - 1546
  • [5] OPIOID EFFECTS ON CONTRACTILITY, CA2+-TRANSIENTS AND INTRACELLULAR PH IN CULTURED CARDIAC MYOCYTES
    ELA, C
    HASIN, Y
    EILAM, Y
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1993, 25 (05) : 599 - 613
  • [6] MULTIPLE EFFECTS OF OPIATES ON INTRACELLULAR CALCIUM LEVEL AND ON CALCIUM-UPTAKE IN 3 NEURONAL CELL-LINES
    FIELDS, A
    GAFNI, M
    ORON, Y
    SARNE, Y
    [J]. BRAIN RESEARCH, 1995, 687 (1-2) : 94 - 102
  • [7] mu-opioid receptor-induced Ca2+ mobilization and astroglial development: Morphine inhibits DNA synthesis and stimulates cellular hypertrophy through a Ca2+-dependent mechanism
    Hauser, KF
    StieneMartin, A
    Mattson, MP
    Elde, RP
    Ryan, SE
    Godleske, CC
    [J]. BRAIN RESEARCH, 1996, 720 (1-2) : 191 - 203
  • [8] Jeon YJ, 1996, MOL PHARMACOL, V50, P334
  • [9] ALTERATION OF CALCIUM MOBILIZATION IN ENDOTHELIAL-CELLS BY VOLATILE ANESTHETICS
    LOEB, AL
    LONGNECKER, DE
    WILLIAMSON, JR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (05) : 1137 - 1142
  • [10] LOPEZ MC, 1993, INT J IMMUNOPHARMACO, V8, P909